Primary biliary cirrhosis

Autoimmunity

Volumn 37, Issue 4, 2004, Pages 325-328

  Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); ANTINUCLEAR ANTIBODY; AUTOANTIBODY; MITOCHONDRION ANTIBODY; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BILIARY CIRRHOSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; PREDICTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TRANSCRIPTION REGULATION;

AUTOANTIBODIES; BIOLOGICAL MARKERS; CELL NUCLEUS; HUMANS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA; PROGNOSIS;

EID: 4444271768     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930410001705411     Document Type: Article

References (35)

1. Mackay, I.R. (1958) "Primary biliary cirrhosis showing a high titre of autoantibody: report of a case study", N Engl. J. Med. 258, 185-188.
2. Shimoda, S., Van de Water, J., Ansari, A., Nakamura, M., Ishibashi, H., Coppel, R.L., et al. (1998) "Identification and precursor frequency analysis of a common T-cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis", J. Clin. Investig. 102, 1831-1840.
3. Kita, H., Lian, Z., Van de Water, J., He, X., Matsumura, S., Kaplan, M., et al. (2002) "Identification of HLA-A2-restricted CD8+ cytotoxic T-cell responses in primary biliary cirrhosis: T-cell activation is augmented by immune complexes cross-presented by dendritic cells", J. Exp. Med. 195, 113-123.
4. Watt F.E., James O.F.W. and Jones D.E.J. (2004) "Patterns of autoimmunity in PBC patients and their families", QJM, in press.
5. Jones, D.E.J. and Donaldson, P.T. (2003) "Genetic factors in the pathogenesis of primary biliary cirrhosis", Clin. Liver Dis. 7, 841-864.
6. Jones, D.E.J. (2003) "Pathogenesis of primary biliary cirrhosis", J. Hepatol. 39, 639-648.
7. Yeaman, S.J., Kirby, J.A. and Jones, D.E.J. (2000) "Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis", Immunol. Rev. 174, 239-249.
8. Yeaman, S.J., Fussey, S.P., Danner, D.J., James, O.F.W., Mutimer, D.J. and Bassendine, M.F. (1988) "Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens", Lancet i, 1067-1070.
9. Van de Water, J., Fregeau, D., Davis, P., Ansari, A., Danner, D., Leung, P., et al. (1988) "Autoantibodies of primary biliary cirrhosis recognise dihydrolipoamide acetyltransferase and inhibit enzyme function", J. Immunol. 141, 2321-2324.
10. Palmer, J.M., Jones, D.E.J., Quinn, J., McHugh, A. and Yeaman, S.J. (1999) "Characterisation of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis", Hepatology 30, 21-26.
11. Quinn, J., Diamond, A.G., Palmer, J.M., James, O.F.W., Bassendine, M.F. and Yeaman, S.J. (1993) "Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment", Hepatology 18, 1384-1391
12. Leung, P.S., Quan, C., Park, O., Van de Water, J., Kurth, M.J., Nantz, M.H., et al. (2003) "Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies", J. Immunol. 170, 5326-5332.
13. Palmer J.M., Robe A.J., Burt A.D., Kirby J.A. and Jones D.E.J. (2004). "Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse", Hepatology, in press.
14. Berg, P.A., Klein, R. and Lindenborn-Fotinos, J. (1986) "Antimitochondrial antibodies in primary biliary cirrhosis", J. Hepatol. 2, 123-131.
15. Klein, R. and Berg, P.A. (1990) "Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognise an epitope of glycogen phosphorylase", Clin. Exp. Immunol. 81, 65-71.
16. Klein, R. and Berg, P.A. (1991) "Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space", Clin. Exp. Immunol. 84, 445-448.
17. Palmer, J.M., Yeaman, S.J., Bassendine, M.F. and James, O.F.W. (1993) "M4 and M9 autoantigens in primary biliary cirrhosis - a negative study", J. Hepatol. 18, 251-254.
18. Doniach, D., Roitt, I.M., Walker, J.G. and Sherlock, S. (1966) "Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications", Clin. Exp. Immunol. 1, 237-262.
19. Lozano, F., Pares, A., Borche, L., Plana, M., Gallart, T., Rodes, J., et al. (1988) "Autoantibodies against nuclear-associated proteins in primary biliary cirrhosis", Hepatology 8, 930-938.
20. Courvalin, J.-C., Lassoued, K., Bartnik, E., Blobel, G. and Wozniak, R.W. (1990) "The 210kD nuclear envelope polypeptide recognised by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore", J. Clin. Investig. 86, 279-285.
21. Nickowitz, R.E., Wozniak, R.W., Schaffner, F. and Worman, H.J. (1994) "Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis", Gastroenterology 106, 193-199.
22. Evans, J., Rueben, A. and Craft, C. (1991) "PBC95K, a 95 kilodalton nuclear autoantigen in primary biliary cirrhosis", Arthritis Rheum. 34, 731-736.
23. Fusconi, M., Cassani, F., Govoni, M., Caselli, A., Farabegoli, F., Lenzi, M., et al. (1991) "Anti-nuclear antibodies of primary biliary cirrhosis recognise 78-92kD and 96-100kD proteins of nuclear bodies", Clin. Exp. Immunol. 83, 291-297.
24. Szostecki, C., Guldner, H.H., Netter, H.J. and Will, H. (1990) "Isolation and charcterisation of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis", J. Immunol. 145, 4338-4347.
25. Sternsdorf, T., Gulder, H.H., Szostecki, C., Grotzinger, T. and Will, H. (1995) "Two nuclear dot associated proteins PML and Sp100 are often coautoimmunogenic in patients with primary biliary cirrhosis", Scand. J. Immunol. 42, 257-268.
26. Metcalf, J.V., Howel, D., James, O.F.W. and Bhopal, R.S. (1996) "Primary biliary cirrhosis: epidemiology helping the clinician", Br. Med. J. 312, 1181-1182.
27. Garrido, M.C. and Hubscher, S.G. (1996) "Accuracy of staging in primary biliary cirrhosis", J. Clin. Path. 49, 556-559.
28. Heathcote, E.J. (2000) "Management of primary biliary cirrhosis", Hepatolology 31, 1005-1013.
29. Jones, D.E.J. (2000) "Autoantigens in primary biliary cirrhosis", J. Clin. Path. 53, 1-8.
30. Heseltine, L., Turner, I.B., Fussey, S.P.M., Kelly, P.J., James, O.F.W., Yeaman, S.J., et al. (1990) "Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression", Gastroenterology 99, 1786-1792.
31. Mitchison, H.C., Bassendine, M.F., Hendrick, A., Bennett, M.K., Bird, A.G., Watson, A.J.B., et al. (1986) "Postitive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?", Hepatology 6, 1279-1284.
32. Metcalf, J.V., Mitchinson, H.C., Palmer, J.M., Jones, D.E.J., Bassendine, M.F. and James, O.F.W. (1996) "Natural history of early primary biliary cirrhosis", Lancet 348, 1399-1402.
33. Van Norstrand, M.D., Malinchoc, M., Lindor, K.D., Therneau, T.M., Gershwin, M.E., Leung, P.S., et al. (1997) "Quantitative measurement of autoantibodies tov recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression", Hepatology 25, 6-11.
34. Invernizzi, P., Podda, M., Battezzati, P.M., Crosignani, A., Zuin, M., Hitchman, E., et al. (2001) "Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis", J. Hepatol. 34, 366-372.
35. Klein, R., Kloppel, G., Garbe, W., Fintelmann, V. and Berg, P.A. (1991) "Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease: a retrospective analysis of 76 patients over 6-18 years", J. Hepatol. 12, 21-27.